Seoul, Seoul-t'ukpyolsi, South Korea In 1989 was created Tong Yang Venture Capital, which is appeared as VC. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Novartis Venture Fund, IDG Ventures Korea.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Manufacturing. Among the various public portfolio startups of the fund, we may underline PharmAbcine
The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2009. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Alpine Capital AS | - |
| China Jianteng Sports Industry Fund | - |
| FinTech Collective | New York, New York, United States |
| Hong Kong X Foundation | China, Hong Kong, Kowloon |
| IncSyn Business Incubation Ltd. | - |
| Indies Capital Partners | Central, Central Region, Singapore |
| Mediphase Venture Partners | Massachusetts, Newton, United States |
| Modalku | East Java, Indonesia, Kebon |
| Savox Investments | - |
| Sawada Holdings | Japan, Shinjuku |
| Seerave Foundation | - |
| SG INCUBATE | Fukuoka, Fukuoka Prefecture, Japan |
| Shangque | China, Jiangsu, Nanjing |
| Sigma Square Capital | Beijing, Beijing, China |
| United States Army | Arlington, United States, Virginia |
| University of Cape Town | Gauteng, NA - South Africa, South Africa |
| VLTCM | China, Hong Kong, Hong Kong Island |
| Zhejiang Lizi Venture Capital | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
PharmAbcine | $6M | 16 Sep 2009 | South Korea, Gyeonggi-do, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
PharmAbcine | $6M | 16 Sep 2009 | South Korea, Gyeonggi-do, South Korea |
